Table 1.
Control Group n = 262 |
STOMP™ Group n=254 |
Odds Ratio (95% Confidence Limits), p value |
|
---|---|---|---|
| |||
Female Sex | 207 (79%) | 193 (77%) | 0.87 (0.57, 1.32), 0.509 |
Number of children | |||
1–2 children (vs. ≥ 3) | 190 (73%) | 174 (68%) | 1.25 (0.85, 1.82), 0.288 |
Age youngest child | 6.2 ± 5.0 | 5.7 ± 4.9 | MD −0.51 (−1.4, 0.4), 0.25 |
Oldest child age | 10.7 ± 6.8 | 10.2 ± 6.4 | MD −0.52 (−1.7, 0.6), 0.375 |
≤High school graduate | 29 (11%) | 27 (11%) | |
Some college | 98 (37%) | 74 (28%) | |
≥Bachelor’s degree (vs. all others) | 134 (51%) | 131 (52%) | 1.02 (0.72, 1.44), 0.930 |
Medical professional with pharmacologic training | 21 (8%) | 23 (9%) | 1.14 (0.61, 2.11), 0.682 |
Opioid familiarity | 109 (42%) | 105 (41%) | 0.96 (0.69, 1.37), 0.835 |
PR Pref | −0.345 ± 3.28 | −0.357 ± 3.62 | 0.013a (−0.59, 0.61), 0.861b |
| |||
Three-day Follow-up | |||
| |||
Number who followed-up | 155 (59%) | 157 (62%) | 1.11 (0.78, 1.57), 0.576 |
Female sex | 119 (77%) | 127 (81%) | 1.33 (0.77, 2.30), 0.315 |
≥Bachelor’s degree (vs. all others) | 87 (56%) | 90 (57%) | 1.05 (0.67, 1.64), 0.831 |
Medical professional with pharmacology training | 16 (10%) | 17 (11%) | 1.05 (0.51, 2.17), 0.885 |
Number of children | |||
1–2 children (vs. ≥ 3) | 41 (27%) | 52 (33%) | 1.37 (0.84, 2.22), 0.211 |
Age youngest child | 6.4 ± 5.1 | 5.6 ± 4.9 | MD −0.78 (−1.9, 0.34), 0.17 |
Oldest child age | 11.0 ± 7.0 | 10.0 ± 6.0 | MD−1.00 (−2.5, 0.45), 0.176 |
Current analgesic use | 58 (39%) | 67 (44%) | 1.09 (0.9, 1.31), 0.391 |
PR Pref | −0.732 ± 3.61 | −1.50 ± 3.42* | 0.77a (−0.02, 1.55), 0.051b |
PR Pref=Pain Relief Preference Score, where −12 reflects highest risk aversion, and +12 a high preference to relieve pain, and 0 reflects ambivalence;
Value is the mean difference;
Mann-Whitney U Test used to compare groups.